We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+21.69%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$150M
AUM Growth
+$13M
Cap. Flow
-$2.13M
Cap. Flow %
-1.42%
Top 10 Hldgs %
33.6%
Holding
92
New
24
Increased
18
Reduced
19
Closed
31

Sector Composition

Rank Sector Weight
1 Healthcare 40.29%
2 Industrials 15.71%
3 Communication Services 12.16%
4 Consumer Discretionary 11.17%
5 Materials 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
76
Insulet
PODD
$9.23B
-36,000
Closed -$1.66M
VRTX icon
77
Vertex Pharmaceuticals
VRTX
$123B
-9,500
Closed -$1.13M
ZTS icon
78
Zoetis
ZTS
$31.2B
-38,000
Closed -$1.64M
SAVE
79
DELISTED
Spirit Airlines, Inc.
SAVE
-23,000
Closed -$1.74M
ALXN
80
DELISTED
Alexion Pharmaceuticals
ALXN
-5,000
Closed -$925K
CORV
81
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
-14,213
Closed -$131K
VSI
82
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
-80,000
Closed -$3.89M
VSI
83
DELISTED
Vitamin Shoppe Inc.
VSI
-44,000
Closed -$2.14M
EVHC
84
DELISTED
Envision Healthcare Holdings Inc
EVHC
-10,354
Closed -$1.07M
CAB
85
DELISTED
Cabela's Inc
CAB
-14,500
Closed -$764K
KATE
86
DELISTED
Kate Spade & Company
KATE
-22,000
Closed -$704K
HNT
87
DELISTED
HEALTH NET INC
HNT
-27,900
Closed -$1.49M
GMCR
88
DELISTED
KEURIG GREEN MTN INC
GMCR
-6,000
Closed -$794K
RCPT
89
PUT
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
-15,000
Closed -$1.84M
SLXP
90
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
-2,500
Closed -$287K
AVNR
91
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
-128,674
Closed -$2.18M
AGN
92
DELISTED
Allergan Inc
AGN
-11,300
Closed -$2.4M

Similar funds

Atika Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Atika Capital Management held 92 positions worth $150M, up 9.5% from $137M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management's Q1 2015 filing shows 24 new, 18 increased, 19 reduced and 31 closed positions. Its largest new stake was Martin Marietta Materials: 28,000 shares worth $3.92M. The largest sale was AbbVie, an estimated $3.76M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Industrials and Communication Services.

  • Atika Capital Management's largest Q1 2015 buy was Martin Marietta Materials: 28,000 shares worth $3.92M.
  • Atika Capital Management added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2015, an estimated $1.63M increase.
  • Atika Capital Management's biggest Q1 2015 reduction was Acadia Pharmaceuticals, cutting an estimated $2.87M.
  • Atika Capital Management fully exited AbbVie in Q1 2015, selling an estimated $3.76M.
  • Atika Capital Management's ten largest holdings make up 34% of its $150M portfolio in Q1 2015.
  • Atika Capital Management opened 24 new positions and closed 31 in Q1 2015.
  • Atika Capital Management's portfolio value rose 9.5% quarter-over-quarter to $150M.

Based on Atika Capital Management's 13F filing for Q1 2015, filed 15 May 2015.